双歧杆菌联合生长抑素、乌司他丁对急性胰腺炎的治疗效果及抗炎机制OA
Therapeutic efficacy and anti-inflammatory mechanism of Bifidobacterium combined with somatostatin and ulinastatin in acute pancreatitis
目的 探究在生长抑素联合乌司他丁常规治疗基础上,加用双歧杆菌强化治疗急性胰腺炎的临床疗效,并分析其对患者外周血单核细胞Toll样受体4(TLR4)/核因子κB(NF-κB)信号通路的影响.方法 前瞻性选取2024年6月至2025年6月南阳市中心医院收治的急性胰腺炎患者86例,根据随机数表法分为对照组(43例)和观察组(43例).对照组给予生长抑素联合乌司他丁治疗,观察组在对照组的基础上联合双歧杆菌治疗.比较两组临床疗效、炎症指标[C反应蛋白(CRP)、白介素-6(IL-6)]水平变化、外周血单核细胞TLR4、NF-κB蛋白表达水平以及不良反应发生情况.结果 观察组总有效率(95.35%)高于对照组(76.74%;χ2值为4.745,P<0.05).治疗7 d后,观察组改良Marshall评分显著低于对照组(P<0.001).治疗7 d后,观察组CRP、IL-6、外周血单核细胞TLR4、NF-κB蛋白表达、外周血血清内毒素水平显著低于对照组(P<0.001).两组不良反应发生率比较,差异无统计学意义(P>0.05).结论 双歧杆菌联合生长抑素、乌司他丁治疗急性胰腺炎疗效确切,能有效缓解患者临床症状、降低炎症反应,其作用机制可能与抑制外周血单核细胞TLR4/NF-κB信号通路激活有关,且用药安全性良好.
Objective To explore the clinical efficacy of adding Bifidobacterium to conventional treatment with somatostatin combined with ulinastatin in patients with acute pancreatitis,and to analyze its influence on the Toll-like receptor 4(TLR4)/nuclear factor-κB(NF-κB)signaling pathway in peripheral blood mononuclear cells.Methods A total of 86 patients with acute pancreatitis admitted to Nanyang Central Hospital from June 2024 to June 2025 were prospectively enrolled and randomly divided into a control group(n=43)and an observation group(n=43)using a random number table method.The control group received somatostatin combined with ulinastatin,while the observation group received additional Bifidobacterium treatment on the basis of the control group.Clinical efficacy,changes in inflammatory markers[C-reactive protein(CRP),interleukin-6(IL-6)],protein expression levels of TLR4 and NF-κB in peripheral blood mononuclear cells,and the incidence of adverse reactions were compared between the two groups.Results The overall response rate in the observation group(95.35%)was higher than that in the control group(76.74%;χ2=4.745,P<0.05).After 7 days of treatment,the modified Marshall score in the observation group was significantly lower than that in the control group(P<0.001).After 7 days of treatment,the levels of CRP,IL-6,protein expression of TLR4 and NF-κB in peripheral blood mononuclear cells,and serum endotoxin levels in peripheral blood in the observation group were significantly lower than those in the control group(P<0.001).There was no statistically significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions The combination of Bifidobacterium with somatostatin and ulinastatin demonstrates definite efficacy in the treatment of acute pancreatitis,effectively alleviating clinical symptoms and reducing inflammatory responses.The mechanism may be related to the inhibition of TLR4/NF-κB signaling pathway activation in peripheral blood mononuclear cells,with a favorable safety profile.
崔罗天;张海洋;冯延冰;郑学典
南阳市中心医院急诊创伤外科,河南 南阳 473000南阳市中心医院急诊创伤外科,河南 南阳 473000南阳市中心医院急诊创伤外科,河南 南阳 473000南阳市中心医院急诊创伤外科,河南 南阳 473000
急性胰腺炎双歧杆菌生长抑素乌司他丁TLR4/NF-κB信号通路
acute pancreatitisBifidobacteriumsomatostatinulinastatinTLR4/NF-κB signaling pathway
《感染、炎症、修复》 2026 (4)
351-356,6
评论